Dr. Mohammad Khan, MD

Dr. Khan practices at Hartford Hospital in Hartford, Connecticut, part of Hartford HealthCare.

Dr. Khan's NPI, 1780069930, was assigned on July 29, 2015. Dr. Khan holds Connecticut license 71936.

Dr. Khan's primary practice is Hartford Hospital, at 80 Seymour Street, Hartford, CT 06102 in Hartford County. The practice phone is (860) 545-5000.

Dr. Khan's primary practice is Hartford Hospital in Hartford, Connecticut, part of Hartford HealthCare. Dr. Khan is also affiliated with Yale New Haven Health Westerly Hospital. The medical group on file is Hartford HealthCare Medical Group Specialists. Dmand AI also links Dr. Khan to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khan practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Khan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Khan's licenses on file in 2 states: Connecticut and Rhode Island.

CMS data shows 917 Medicare services from Dr. Khan across 6 procedure codes in 2024, for 320 Medicare patients. Medicare paid $80,010 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 320 Medicare patients who saw Dr. Khan in 2024. The largest group is 75 to 84, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khan's median patient age at 66, with 47% women.

In 2024, Dr. Khan wrote 516 Medicare Part D claims for 200 patients. 85% of them were for generic drugs. CMS names the drug for 230 of them, across 13 drugs with 11 or more claims each, at $9,490 in total drug cost. In 2023, CMS named 285 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Khan for performance year 2024, reported individually. Dr. Khan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 97 papers to Dr. Khan, published from 2011 to 2024. 2020 was the busiest year, with 15. The most frequent topics are Melanoma, Skin Neoplasms and Radiotherapy Dosage. Dr. Khan has published most often in Int J Radiat Oncol Biol Phys. Dr. Khan's most frequent co-authors are Zachary Scott Buchwald, MD, PhD, Natia Esiashvili, MD and David H. Lawson, MD.

Dmand AI links Dr. Khan to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Severe Acute Respiratory Syndrome, Breast Neoplasms and Cytokine Release Syndrome. Emory University sponsors the most, 3.

CMS Open Payments shows 5 general payments to Dr. Khan from 5 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $75.